top of page

Carisma Therapeutics' CEO on refocusing its pipeline this week and what the company has learned in the clinic

CEO Steven Kelly described the scientific basis of pipeline changes they have made this week and when we can expect to see data throughout the remainder of the year.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page